Source | Evidence on protein | Close homologs |
---|---|---|
Cuervo et al. | no | yes: 0 |
Hassani et al. | no | yes: 0 |
Forrest at al. (metacyclic) | no | yes: 0 |
Forrest at al. (procyclic) | no | yes: 0 |
Silverman et al. | no | yes: 0 |
Pissara et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Pires et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Silverman et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Jamdhade et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
DeepLoc | ||
SignalP6 | no | yes: 0, no: 11 |
NetGPI | no | yes: 0, no: 11 |
Related structures:
AlphaFold database: A4HIQ0
Leishmania | From | To | Domain/Motif | Score |
---|---|---|---|---|
CLV_C14_Caspase3-7 | 274 | 278 | PF00656 | 0.318 |
CLV_NRD_NRD_1 | 79 | 81 | PF00675 | 0.562 |
CLV_PCSK_KEX2_1 | 161 | 163 | PF00082 | 0.413 |
CLV_PCSK_KEX2_1 | 289 | 291 | PF00082 | 0.397 |
CLV_PCSK_KEX2_1 | 79 | 81 | PF00082 | 0.645 |
CLV_PCSK_PC1ET2_1 | 161 | 163 | PF00082 | 0.413 |
CLV_PCSK_PC1ET2_1 | 289 | 291 | PF00082 | 0.455 |
CLV_PCSK_SKI1_1 | 276 | 280 | PF00082 | 0.383 |
CLV_Separin_Metazoa | 194 | 198 | PF03568 | 0.356 |
DEG_APCC_DBOX_1 | 176 | 184 | PF00400 | 0.409 |
DEG_Nend_UBRbox_1 | 1 | 4 | PF02207 | 0.642 |
DOC_CKS1_1 | 38 | 43 | PF01111 | 0.608 |
DOC_CYCLIN_RxL_1 | 208 | 219 | PF00134 | 0.244 |
DOC_MAPK_gen_1 | 64 | 73 | PF00069 | 0.470 |
DOC_USP7_MATH_1 | 109 | 113 | PF00917 | 0.430 |
DOC_USP7_UBL2_3 | 129 | 133 | PF12436 | 0.432 |
DOC_USP7_UBL2_3 | 96 | 100 | PF12436 | 0.421 |
DOC_WW_Pin1_4 | 240 | 245 | PF00397 | 0.301 |
DOC_WW_Pin1_4 | 37 | 42 | PF00397 | 0.606 |
LIG_14-3-3_CanoR_1 | 150 | 154 | PF00244 | 0.382 |
LIG_14-3-3_CanoR_1 | 174 | 184 | PF00244 | 0.364 |
LIG_14-3-3_CanoR_1 | 197 | 202 | PF00244 | 0.253 |
LIG_14-3-3_CanoR_1 | 72 | 78 | PF00244 | 0.598 |
LIG_14-3-3_CanoR_1 | 79 | 87 | PF00244 | 0.542 |
LIG_Actin_WH2_2 | 56 | 74 | PF00022 | 0.375 |
LIG_Actin_WH2_2 | 82 | 97 | PF00022 | 0.380 |
LIG_BIR_III_4 | 277 | 281 | PF00653 | 0.264 |
LIG_BRCT_BRCA1_1 | 311 | 315 | PF00533 | 0.515 |
LIG_deltaCOP1_diTrp_1 | 83 | 91 | PF00928 | 0.364 |
LIG_FHA_1 | 113 | 119 | PF00498 | 0.469 |
LIG_FHA_1 | 135 | 141 | PF00498 | 0.498 |
LIG_FHA_1 | 43 | 49 | PF00498 | 0.445 |
LIG_FHA_2 | 174 | 180 | PF00498 | 0.456 |
LIG_FHA_2 | 189 | 195 | PF00498 | 0.451 |
LIG_FHA_2 | 223 | 229 | PF00498 | 0.410 |
LIG_FHA_2 | 304 | 310 | PF00498 | 0.411 |
LIG_LIR_Gen_1 | 142 | 153 | PF02991 | 0.413 |
LIG_LIR_Gen_1 | 191 | 199 | PF02991 | 0.380 |
LIG_LIR_Gen_1 | 254 | 262 | PF02991 | 0.249 |
LIG_LIR_Gen_1 | 44 | 53 | PF02991 | 0.418 |
LIG_LIR_Gen_1 | 84 | 94 | PF02991 | 0.347 |
LIG_LIR_Nem_3 | 142 | 148 | PF02991 | 0.408 |
LIG_LIR_Nem_3 | 182 | 187 | PF02991 | 0.304 |
LIG_LIR_Nem_3 | 191 | 195 | PF02991 | 0.363 |
LIG_LIR_Nem_3 | 254 | 258 | PF02991 | 0.352 |
LIG_LIR_Nem_3 | 277 | 282 | PF02991 | 0.459 |
LIG_LIR_Nem_3 | 44 | 49 | PF02991 | 0.434 |
LIG_LIR_Nem_3 | 84 | 90 | PF02991 | 0.358 |
LIG_PDZ_Class_2 | 310 | 315 | PF00595 | 0.359 |
LIG_SH2_CRK | 38 | 42 | PF00017 | 0.473 |
LIG_SH2_CRK | 55 | 59 | PF00017 | 0.437 |
LIG_SH2_STAP1 | 248 | 252 | PF00017 | 0.473 |
LIG_SH2_STAT5 | 257 | 260 | PF00017 | 0.395 |
LIG_SH2_STAT5 | 55 | 58 | PF00017 | 0.567 |
LIG_SH3_3 | 238 | 244 | PF00018 | 0.328 |
LIG_TRAF2_1 | 191 | 194 | PF00917 | 0.395 |
LIG_UBA3_1 | 198 | 204 | PF00899 | 0.324 |
MOD_CK1_1 | 107 | 113 | PF00069 | 0.474 |
MOD_CK1_1 | 146 | 152 | PF00069 | 0.409 |
MOD_CK1_1 | 20 | 26 | PF00069 | 0.420 |
MOD_CK1_1 | 222 | 228 | PF00069 | 0.524 |
MOD_CK1_1 | 303 | 309 | PF00069 | 0.493 |
MOD_CK2_1 | 188 | 194 | PF00069 | 0.545 |
MOD_CK2_1 | 222 | 228 | PF00069 | 0.435 |
MOD_CK2_1 | 253 | 259 | PF00069 | 0.270 |
MOD_GlcNHglycan | 106 | 109 | PF01048 | 0.406 |
MOD_GlcNHglycan | 111 | 114 | PF01048 | 0.436 |
MOD_GlcNHglycan | 22 | 25 | PF01048 | 0.555 |
MOD_GlcNHglycan | 273 | 276 | PF01048 | 0.481 |
MOD_GlcNHglycan | 73 | 76 | PF01048 | 0.514 |
MOD_GSK3_1 | 100 | 107 | PF00069 | 0.409 |
MOD_GSK3_1 | 13 | 20 | PF00069 | 0.416 |
MOD_GSK3_1 | 175 | 182 | PF00069 | 0.373 |
MOD_NEK2_1 | 53 | 58 | PF00069 | 0.419 |
MOD_NEK2_1 | 71 | 76 | PF00069 | 0.427 |
MOD_PIKK_1 | 112 | 118 | PF00454 | 0.441 |
MOD_PKA_1 | 79 | 85 | PF00069 | 0.512 |
MOD_PKA_2 | 149 | 155 | PF00069 | 0.391 |
MOD_PKA_2 | 173 | 179 | PF00069 | 0.418 |
MOD_PKA_2 | 71 | 77 | PF00069 | 0.492 |
MOD_PKA_2 | 79 | 85 | PF00069 | 0.454 |
MOD_Plk_1 | 253 | 259 | PF00069 | 0.440 |
MOD_Plk_1 | 303 | 309 | PF00069 | 0.463 |
MOD_Plk_1 | 85 | 91 | PF00069 | 0.359 |
MOD_Plk_4 | 149 | 155 | PF00069 | 0.391 |
MOD_Plk_4 | 179 | 185 | PF00069 | 0.336 |
MOD_ProDKin_1 | 240 | 246 | PF00069 | 0.298 |
MOD_ProDKin_1 | 37 | 43 | PF00069 | 0.609 |
MOD_SUMO_rev_2 | 61 | 65 | PF00179 | 0.446 |
MOD_SUMO_rev_2 | 92 | 102 | PF00179 | 0.381 |
TRG_DiLeu_BaEn_3 | 193 | 199 | PF01217 | 0.381 |
TRG_DiLeu_BaLyEn_6 | 182 | 187 | PF01217 | 0.251 |
TRG_DiLeu_BaLyEn_6 | 241 | 246 | PF01217 | 0.303 |
TRG_DiLeu_BaLyEn_6 | 291 | 296 | PF01217 | 0.258 |
TRG_ENDOCYTIC_2 | 55 | 58 | PF00928 | 0.567 |
TRG_Pf-PMV_PEXEL_1 | 234 | 238 | PF00026 | 0.404 |
Protein | Taxonomy | Sequence identity | Coverage |
---|---|---|---|
A0A0N1I463 | Leptomonas seymouri | 74% | 99% |
A0A0S4JPV6 | Bodo saltans | 54% | 98% |
A0A1X0P1E1 | Trypanosomatidae | 62% | 97% |
A0A3S7X3T4 | Leishmania donovani | 91% | 100% |
A0A422P0S4 | Trypanosoma rangeli | 63% | 97% |
A4I661 | Leishmania infantum | 91% | 100% |
C9ZRC1 | Trypanosoma brucei gambiense (strain MHOM/CI/86/DAL972) | 62% | 97% |
E9B190 | Leishmania mexicana (strain MHOM/GT/2001/U1103) | 91% | 100% |
Q4Q6X4 | Leishmania major | 92% | 100% |
V5BMS9 | Trypanosoma cruzi | 63% | 97% |